Greedy Insider · Filing
VNDA · Buy · Duncan Charles Cliff
Duncan Charles Cliff (Director) bought 750 shares of Vanda Pharmaceuticals Inc. (VNDA) at $3.80, about $3K, on Nov 3, 2026, filed with the SEC on Nov 5, 2026.
Greediness Score 30 · Weak · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001193125-26-449902